2023
DOI: 10.1007/s12033-023-00714-1
|View full text |Cite
|
Sign up to set email alerts
|

miR-139-3p/Wnt5A Axis Inhibits Metastasis in Hepatoblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“… 65 Moreover, as a terminal disease stage of NASH, liver cirrhosis could cause cirrhotic cardiomyopathy, where hsa‐miR‐483‐3p was found to be a key miRNA to promote its occurrence and progression. 66 However, hsa‐miR‐139‐3p has only been proved to participate in various cancers, 67 , 68 and there has been no research about its relationship with psoriasis, NASH, or other metabolic diseases, which suggests more further studies. As for hsa‐miR‐142‐3p and hsa‐miR‐142‐5p, some researchers identified their participation in metabolic diseases, including insulin resistance and obesity in preadolescent children 69 , 70 as well as metabolic syndrome‐associated cardiovascular disease by regulating metabolic and inflammatory signals.…”
Section: Discussionmentioning
confidence: 99%
“… 65 Moreover, as a terminal disease stage of NASH, liver cirrhosis could cause cirrhotic cardiomyopathy, where hsa‐miR‐483‐3p was found to be a key miRNA to promote its occurrence and progression. 66 However, hsa‐miR‐139‐3p has only been proved to participate in various cancers, 67 , 68 and there has been no research about its relationship with psoriasis, NASH, or other metabolic diseases, which suggests more further studies. As for hsa‐miR‐142‐3p and hsa‐miR‐142‐5p, some researchers identified their participation in metabolic diseases, including insulin resistance and obesity in preadolescent children 69 , 70 as well as metabolic syndrome‐associated cardiovascular disease by regulating metabolic and inflammatory signals.…”
Section: Discussionmentioning
confidence: 99%